Cargando…

Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010

Please cite this paper as: Haaheim and Katz (2011) Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010. Influenza and Other Respiratory Viruses 5(4), 288–295 The emergence of a novel swine‐origin pan...

Descripción completa

Detalles Bibliográficos
Autores principales: Haaheim, Lars R., Katz, Jacqueline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634548/
https://www.ncbi.nlm.nih.gov/pubmed/21651740
http://dx.doi.org/10.1111/j.1750-2659.2011.00242.x
_version_ 1782399379718537216
author Haaheim, Lars R.
Katz, Jacqueline M.
author_facet Haaheim, Lars R.
Katz, Jacqueline M.
author_sort Haaheim, Lars R.
collection PubMed
description Please cite this paper as: Haaheim and Katz (2011) Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010. Influenza and Other Respiratory Viruses 5(4), 288–295 The emergence of a novel swine‐origin pandemic influenza virus in 2009, together with the continuing circulation of highly pathogenic avian H5N1 viruses and the urgent global need to produce effective vaccines against such public health threats, has prompted a renewed interest in improving our understanding of the immune correlates of protection against influenza. As new influenza vaccine technologies, including non‐HA based approaches and novel production platforms are developed and undergo clinical evaluation, it has become clear that existing immune correlates such as serum hemagglutination‐inhibition antibodies may be unsuitable to estimate vaccine immunogenicity and protective efficacy of such vaccines. This International Society for Influenza and other Respiratory Virus Diseases (ISIRV) sponsored international meeting held in Miami, Florida USA on March 1–3, 2010, brought together scientists from industry, academia, and government agencies that develop and evaluate seasonal and pandemic influenza vaccines and scientists from regulatory authorities that approve them, to identify approaches to develop expanded immune correlates of protection to aid in vaccine licensure.
format Online
Article
Text
id pubmed-4634548
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-46345482015-11-30 Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010 Haaheim, Lars R. Katz, Jacqueline M. Influenza Other Respir Viruses Meeting Report Please cite this paper as: Haaheim and Katz (2011) Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010. Influenza and Other Respiratory Viruses 5(4), 288–295 The emergence of a novel swine‐origin pandemic influenza virus in 2009, together with the continuing circulation of highly pathogenic avian H5N1 viruses and the urgent global need to produce effective vaccines against such public health threats, has prompted a renewed interest in improving our understanding of the immune correlates of protection against influenza. As new influenza vaccine technologies, including non‐HA based approaches and novel production platforms are developed and undergo clinical evaluation, it has become clear that existing immune correlates such as serum hemagglutination‐inhibition antibodies may be unsuitable to estimate vaccine immunogenicity and protective efficacy of such vaccines. This International Society for Influenza and other Respiratory Virus Diseases (ISIRV) sponsored international meeting held in Miami, Florida USA on March 1–3, 2010, brought together scientists from industry, academia, and government agencies that develop and evaluate seasonal and pandemic influenza vaccines and scientists from regulatory authorities that approve them, to identify approaches to develop expanded immune correlates of protection to aid in vaccine licensure. Blackwell Publishing Ltd 2011-03-21 2011-07 /pmc/articles/PMC4634548/ /pubmed/21651740 http://dx.doi.org/10.1111/j.1750-2659.2011.00242.x Text en © 2011 Blackwell Publishing Ltd
spellingShingle Meeting Report
Haaheim, Lars R.
Katz, Jacqueline M.
Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
title Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
title_full Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
title_fullStr Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
title_full_unstemmed Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
title_short Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
title_sort immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, miami, fl, usa, march 1–3, 2010
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634548/
https://www.ncbi.nlm.nih.gov/pubmed/21651740
http://dx.doi.org/10.1111/j.1750-2659.2011.00242.x
work_keys_str_mv AT haaheimlarsr immunecorrelatesofprotectionagainstinfluenzachallengesforlicensureofseasonalandpandemicinfluenzavaccinesmiamiflusamarch132010
AT katzjacquelinem immunecorrelatesofprotectionagainstinfluenzachallengesforlicensureofseasonalandpandemicinfluenzavaccinesmiamiflusamarch132010